Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GO TEST Overture
2020-005721-82Phase 4Active
- Sponsor
- VieCuri Medisch Centrum
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of allopurinol, febuxostat and benzbromarone in gout (2 arms), sponsored by VieCuri Medisch Centrum. Primary endpoint: Adapted gout remission at 24 months. Started Jan 2021; status: active.
02
Drugs
allopurinolfebuxostatbenzbromarone
03
Conditions
gout
Beyond the preview
Go deeper on 2020-005721-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005721-82.